The GLP-1 muscle-loss conversation should not end with DXA
All these cells express chemoreceptors that detect luminal contents and initiate hormone release, influencing food intake, insulin secretion, and intestinal motility (9294)
While effective for obesity management, ongoing research and vigilant patient monitoring are essential to address and mitigate potential risks associated with GLP-1 RAs [87] [88]
( Epub 2017 Oct 26 PMID: 29072533 ) Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M (2023) Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss
Individual results may vary based on medical history, lifestyle factors, and adherence to treatment plans.
382 Through this sophisticated molecular regulation, PF1801 not only alleviates inflammation and necrosis in muscle fibers but also enhances the energy and antioxidant status of muscle cells